Giordano Natasha has filed 3 insider transactions across 2 companies since November 2023.
Most recent transaction: a grant/award of 38320 shares of ORAGENICS INC ($OGEN) on December 11, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 11, 2025 | ORAGENICS INC | $OGEN | Giordano Natasha | Director | A | Non-Employee Director Option (Right to Buy) | 38320 | $0.00 | 38,320.0000 | 4,168,223 | 9999.99% | 0.92% |
| Dec. 11, 2025 | ORAGENICS INC | $OGEN | Giordano Natasha | Director | A | Non-Employee Director Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 4,168,223 | 9999.99% | 3.00% |
| Nov. 1, 2023 | Matinas BioPharma Holdings, Inc. | $MTNB | Giordano Natasha | Director | A | Stock option (right to buy) | 437244 | $0.00 | 437,244.0000 | 0 | 9999.99% | 0.00% |